chemotherapy
breast
cancer
majority
cancer
patients
referred
chemotherapy
far
advanced
stages
disease
difficulty
deliver
ing
effective
dose
oncolytic
agent
involved
areas
may
limit
results
treatment
unless
patients
tumor
un
usually
responsive
one
variability
re
sponse
apparently
similar
cases
cancer
cell
type
become
creasingly
evident
puzzling
fact
per
cent
patients
breast
cancer
live
years
treatment
decisions
choice
chemother
apy
hormone
therapy
well
choice
chemotherapeutic
agent
employed
may
difficult
experience
increases
usefulness
chemotherapy
treatment
cancer
becoming
increasingly
apparent
also
come
apparent
chemotherapy
cannot
regarded
a
curative
procedure
advanced
cancer
even
though
occasional
patient
ap
pears
cured
however
value
oncolytic
agents
prolonging
useful
survival
time
ameliorating
many
dis
tressing
symptoms
associated
cancer
providing
physician
extra
tool
a
positive
program
care
cancer
patient
established
